Survey on current treatments for pain after spinal cord damage.
Acupuncture Therapy
Analgesics, Opioid
/ therapeutic use
Buprenorphine
/ therapeutic use
Cognitive Behavioral Therapy
Developed Countries
Developing Countries
Humans
Implantable Neurostimulators
Medical Marijuana
/ therapeutic use
Mindfulness
Nurse Practitioners
Pain Management
/ methods
Physical Therapists
Physician Assistants
Physicians
Practice Patterns, Physicians'
Spinal Cord Injuries
/ rehabilitation
Surveys and Questionnaires
Journal
Spinal cord series and cases
ISSN: 2058-6124
Titre abrégé: Spinal Cord Ser Cases
Pays: England
ID NLM: 101680856
Informations de publication
Date de publication:
2019
2019
Historique:
received:
08
11
2018
revised:
14
01
2019
accepted:
24
01
2019
entrez:
8
2
2019
pubmed:
8
2
2019
medline:
1
5
2020
Statut:
epublish
Résumé
An online questionnaire. To assess the international spinal cord medicine and rehabilitation community's utilization of pharmacological and non-pharmacological treatments for spinal cord damage (SCD)-related pain and to determine whether approaches to SCD-related pain differ between developed and less developed nations. An international collaboration of authors. An on-line survey querying availability and utilization of a number of approaches to SCD-related pain was developed, distributed, and made available for 6 months. Responses were analyzed for the entire cohort and according to participants' descriptions of their home nations' economies. A total of 153 responses were submitted, mostly from developed nations. Nearly three quarters of subjects reported offering their patients with SCD narcotics; only 13% reported offering their patients with SCD medical cannabis. Subjects from developing countries were more likely than those from developed countries to prescribe buprenorphine (20.0% vs 15.6%; Most spinal cord medicine clinicians employ a multimodal approach to pain. There are significant differences in utilization of pharmacologic and non-pharmacologic approach to SCD-related pain between clinicians from more and less developed countries.
Identifiants
pubmed: 30729038
doi: 10.1038/s41394-019-0160-5
pii: 160
pmc: PMC6363782
doi:
Substances chimiques
Analgesics, Opioid
0
Medical Marijuana
0
Buprenorphine
40D3SCR4GZ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
14Déclaration de conflit d'intérêts
Compliance with ethical standardsThe authors declare that they have no conflict of interest.
Références
J Neurotrauma. 2004 Oct;21(10):1371-83
pubmed: 15672628
Arch Phys Med Rehabil. 2010 May;91(5):816-31
pubmed: 20434623
Am J Phys Med Rehabil. 2010 Oct;89(10):840-8
pubmed: 20855984
Spinal Cord. 2016 Sep;54(9):656-61
pubmed: 26620877
J Neurotrauma. 2016 Nov 1;33(21):1958-1968
pubmed: 27080545
Spinal Cord Ser Cases. 2018 Jul 27;4:65
pubmed: 30083394
Spinal Cord. 2018 Aug;56(8):750-761
pubmed: 29581519
Neurology. 2013 Feb 5;80(6):533-9
pubmed: 23345639
Spinal Cord Ser Cases. 2018 Jul 27;4:66
pubmed: 30083395
J Spinal Cord Med. 2006;29(2):109-17
pubmed: 16739554
Ann Neurol. 2016 Apr;79(4):569-78
pubmed: 26814620
Arch Phys Med Rehabil. 2014 Nov;95(11):2180-6
pubmed: 24992021
Acupunct Med. 2011 Jun;29(2):108-15
pubmed: 21474490
J Rehabil Med. 2016 Nov 11;48(10):853-860
pubmed: 27834436
Top Spinal Cord Inj Rehabil. 2015 Spring;21(2):166-73
pubmed: 26364286
Pain. 2011 Feb;152(2):267-73
pubmed: 21078545
Pain Physician. 2017 Jan-Feb;20(1):E53-E63
pubmed: 28072797
J Pain. 2016 Sep;17(9):982-1000
pubmed: 27286745
Spinal Cord. 2006 Feb;44(2):95-105
pubmed: 16130026
Clin Rehabil. 2003 Feb;17(1):21-9
pubmed: 12617376
Spinal Cord. 2016 Aug;54 Suppl 1:S14-23
pubmed: 27444715
Clin J Pain. 2007 Jun;23(5):383-91
pubmed: 17515736
J Spinal Cord Med. 2017 Jul;40(4):432-438
pubmed: 26869339
Spinal Cord. 2013 Jan;51(1):23-6
pubmed: 22547044